Zn-Phenanthroline-Dicarboxylate Complex: A Dual Inhibitor of COX-2 and 5-LOX Enzymes

被引:0
|
作者
Rambabu, Darsi [1 ]
Sharma, Shilpa [2 ]
Mayank [3 ]
Singh, Narinder [2 ]
Shagun [4 ]
Pooja [5 ]
机构
[1] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain La Neuve, Belgium
[2] Indian Inst Technol Ropar, Dept Chem, Rupnagar 140001, India
[3] Univ Coll Pharm, Guru Kashi Univ, Talwandi Sabo 151302, India
[4] Indian Inst Technol Mandi, Sch Chem Sci, Mandi 175001, India
[5] DAV Coll, Post Grad Dept Chem, Jalandhor 144008, Punjab, India
来源
CHEMISTRYSELECT | 2024年 / 9卷 / 23期
关键词
COX-2; 5-LOX; Inhibitors; Metal Complexes; Crystal Structures; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2; COX-2; 5-LIPOXYGENASE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of new phenanthroline-based metal complexes, coordination polymers are synthesized using 1,10-phenanthroline 2,9-dicarboxylate (PDA) and different metal salts including tin (R-1 to R-3), manganese (R-4), ruthenium (R-5), and zinc (R-6) respectively. The inhibitory activities of synthesized coordination compounds are evaluated towards COX-2 (cyclooxygenase-2) and 5-LOX (5-lipoxygenase) enzymes. Among all the metal-organic coordination complexes, Zn-PDA (R-6) shows most prominent inhibitory activity than other systems with the IC50 value of 0.0524 mu g/mL and 0.834 mu g/mL for both COX-2 and 5-LOX enzymes, respectively. The synthesized systems were also evaluated for their activity against COX-1 and standard COX-2 inhibitors viz. Rofecoxib and Aspirin. The rationale for R-6 being the most potent metal complex for dual COX-2 and 5-LOX inhibition is demonstrated using docking studies. A series of Metal-phenanthroline-carboxylate- coordination compounds (R1 to R6) were designed and synthesized. Among all the metal complexes tested for inhibitory activities for COX-2 and 5-LOX enzymes, the activities of R-1 and R-6 were found to be most potent. image
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations
    Thiel, Christoph
    Smit, Ines
    Baier, Vanessa
    Cordes, Henrik
    Fabry, Brigida
    Blank, Lars Mathias
    Kuepfer, Lars
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2018, 4
  • [22] Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors
    El-Miligy, Mostafa M. M.
    Al-Kubeisi, Ahmed K.
    Bekhit, Mohamed G.
    El-Zemity, Saad R.
    Nassra, Rasha A.
    Hazzaa, Aly A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01) : 294 - 308
  • [23] Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach
    Jacob, Jaismy P.
    Manju, S. L.
    Ethiraj, K. R.
    Elias, Geetha
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 121 : 356 - 381
  • [24] Structure Based Library Design (SBLD) for new 1,4-dihydropyrimidine scaffold as simultaneous COX-1/COX-2 and 5-LOX inhibitors
    Lokwani, Deepak
    Azad, Rajaram
    Sarkate, Aniket
    Reddanna, Pallu
    Shinde, Devanand
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 4533 - 4543
  • [25] Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors
    Gedawy, Ehab M.
    Kassab, Asmaa E.
    El Kerdawy, Ahmed M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189
  • [26] Dual anti-inflammatory activities of COX-2/5-LOX driven by kratom alkaloid extracts in lipopolysaccharide-induced RAW 264.7 cells
    Rahmawati, Siti Irma
    Indriani, Dwi Wahyu
    Ningsih, Febby Nurdiya
    Hardhiyuna, Mutia
    Firdayani, Firdayani
    Ahmadi, Peni
    Rosyidah, A'liyatur
    Septiana, Eris
    Dharmayanti, Ni Luh Putu Indi
    Bayu, Asep
    Putra, Masteria Yunovilsa
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] New quinoline/1,2,4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study
    Mohassab, Aliaa M.
    Hassan, Heba A.
    Abdelhamid, Dalia
    Gouda, Ahmed M.
    Gomaa, Hesham A. M.
    Youssif, Bahaa G. M.
    Radwan, Mohamed O.
    Fujita, Mikako
    Otsuka, Masami
    Abdel-Aziz, Mohamed
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1244
  • [28] In vitro COX-1, COX-2 and 5-LOX inhibitory activity of plant family Ranunculaceae
    Malik, J.
    Landa, P.
    Kutil, Z.
    Marsik, P.
    Kokoska, L.
    PLANTA MEDICA, 2011, 77 (12) : 1434 - 1435
  • [29] Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy-dual inhibition of COX-2 and 5-LOX enzymes
    Jacob, Jaismy
    Manju, S. L.
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (01) : 236 - 257
  • [30] Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors
    Ding, Xiaoling
    Zhu, Chen
    Qiang, Hui
    Zhou, Xiaorong
    Zhou, Guoxiong
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (07) : 486 - 490